U.S., Sept. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07175922) titled 'Research Into the Expression of the csgA-gene and How it Changes in Patients With Parkinson's Disease' on July 22.
Brief Summary: This study seeks to understand the prevalence and variability of a gut bacteria gene called csgA in people with Parkinson's Disease. This understanding could inform development of potential new therapies targeting the gut in Parkinson's Disease.
Study Start Date: Sept. 14
Study Type: OBSERVATIONAL
Condition:
Parkinsons Disease (PD)
Recruitment Status: RECRUITING
Sponsor: Axial Therapeutics, Inc.
Disclaimer: Curated by HT Syndication....